Business
Acquisition of 30% of Vortex Biotech Holdings
Acquisition of 30% of Vortex Biotech Holdings.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 5351K\n NetScientific PLC\n 06 May 2022\n \n \n \n \n \n NetScientific plc\n \n \n \n \n \n (\n \"\n NetScientific\n \"\n , the \"Group\" or the \"Company\n \n \"\n \n )\n \n \n \n Acquisition of 30% of Vortex Biotech Holdings\n \n \n \n \n \n NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group announces the conditional acquisition of a 30 per cent. stake in Vortex Biotech Holdings Ltd (\"VBHL\") (the \"Acquisition\"). The Acquisition is conditional upon the receipt by Deeptech Disruptive Growth Investments Ltd (\"Deeptech\") of a customary HMRC tax clearance relating to the restructuring of VBHL. Upon completion, immediately before the Acquisition, of the proposed restructuring described below, VBHL will be the owner of c.95 per cent. of Vortex BioSciences, Inc. (\"Vortex US\") and 100 per cent. of Vortex Liquid Biopsy Solutions Limited (\"Vortex UK\" - together \"Vortex\").\n \n Highlights\n \n \n · Group regains a significant stake in Vortex with a matured technology platform\n \n · Board believes substantial upside potential through a multi-pronged growth strategy focused on product and cartridge sales, launching a services lab business, and exploring liquid biopsy opportunities\n \n · Vortex active in the multi-billion oncology research and liquid biopsy markets, which are estimated to grow at 10-14% per annum\n \n Background to and rationale for the Acquisition\n \n The Group previously held a c.95 per cent. interest in Vortex US, however the Company's previous management opted to sell this interest (together with historic debts of c.$33 million) to Deeptech on 22 March 2019 as it concluded that the Group was no longer in a position to provide financial support to Vortex US.\n \n The sale to Deeptech was managed by EMV Capital Ltd (\"EMV Capital\") (which at that time was not owned by NetScientific). Thereafter, EMV Capital entered into a fundraising and incubation support services agreement with Vortex US on 16 June 2020 (\"Services Agreement\") and a management agreement with Deeptech on 5 August 2020 whereby, EMV Capital agreed to provide certain investment advisory services to Deeptech in respect of, inter alia, Vortex (\"Management Agreement\"). EMV Capita...